Apellis Pharmaceuticals Statistics
Total Valuation
APLS has a market cap or net worth of $2.97 billion. The enterprise value is $2.97 billion.
| Market Cap | 2.97B |
| Enterprise Value | 2.97B |
Important Dates
The next estimated earnings date is Friday, February 27, 2026, before market open.
| Earnings Date | Feb 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
APLS has 126.53 million shares outstanding. The number of shares has increased by 4.30% in one year.
| Current Share Class | 126.53M |
| Shares Outstanding | 126.53M |
| Shares Change (YoY) | +4.30% |
| Shares Change (QoQ) | +3.21% |
| Owned by Insiders (%) | 3.24% |
| Owned by Institutions (%) | 91.77% |
| Float | 89.35M |
Valuation Ratios
The trailing PE ratio is 65.59.
| PE Ratio | 65.59 |
| Forward PE | n/a |
| PS Ratio | 2.90 |
| Forward PS | 3.55 |
| PB Ratio | 7.41 |
| P/TBV Ratio | 7.41 |
| P/FCF Ratio | 37.79 |
| P/OCF Ratio | 37.69 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 36.15, with an EV/FCF ratio of 37.73.
| EV / Earnings | 65.96 |
| EV / Sales | 2.92 |
| EV / EBITDA | 36.15 |
| EV / EBIT | 36.90 |
| EV / FCF | 37.73 |
Financial Position
The company has a current ratio of 3.54, with a Debt / Equity ratio of 1.18.
| Current Ratio | 3.54 |
| Quick Ratio | 2.99 |
| Debt / Equity | 1.18 |
| Debt / EBITDA | 5.04 |
| Debt / FCF | 6.05 |
| Interest Coverage | 1.79 |
Financial Efficiency
Return on equity (ROE) is 14.10% and return on invested capital (ROIC) is 23.93%.
| Return on Equity (ROE) | 14.10% |
| Return on Assets (ROA) | 5.13% |
| Return on Invested Capital (ROIC) | 23.93% |
| Return on Capital Employed (ROCE) | 10.32% |
| Weighted Average Cost of Capital (WACC) | 6.06% |
| Revenue Per Employee | $1.43M |
| Profits Per Employee | $63,361 |
| Employee Count | 710 |
| Asset Turnover | 1.04 |
| Inventory Turnover | 3.25 |
Taxes
In the past 12 months, APLS has paid $1.70 million in taxes.
| Income Tax | 1.70M |
| Effective Tax Rate | 3.63% |
Stock Price Statistics
The stock price has decreased by -22.72% in the last 52 weeks. The beta is 0.24, so APLS's price volatility has been lower than the market average.
| Beta (5Y) | 0.24 |
| 52-Week Price Change | -22.72% |
| 50-Day Moving Average | 23.37 |
| 200-Day Moving Average | 22.10 |
| Relative Strength Index (RSI) | 53.49 |
| Average Volume (20 Days) | 3,929,195 |
Short Selling Information
The latest short interest is 18.11 million, so 14.31% of the outstanding shares have been sold short.
| Short Interest | 18.11M |
| Short Previous Month | 16.12M |
| Short % of Shares Out | 14.31% |
| Short % of Float | 20.27% |
| Short Ratio (days to cover) | 6.39 |
Income Statement
In the last 12 months, APLS had revenue of $1.02 billion and earned $44.99 million in profits. Earnings per share was $0.36.
| Revenue | 1.02B |
| Gross Profit | 605.05M |
| Operating Income | 80.41M |
| Pretax Income | 46.68M |
| Net Income | 44.99M |
| EBITDA | 82.08M |
| EBIT | 80.41M |
| Earnings Per Share (EPS) | $0.36 |
Balance Sheet
The company has $480.23 million in cash and $475.37 million in debt, with a net cash position of $4.86 million or $0.04 per share.
| Cash & Cash Equivalents | 480.23M |
| Total Debt | 475.37M |
| Net Cash | 4.86M |
| Net Cash Per Share | $0.04 |
| Equity (Book Value) | 401.17M |
| Book Value Per Share | 3.17 |
| Working Capital | 711.15M |
Cash Flow
In the last 12 months, operating cash flow was $78.86 million and capital expenditures -$225,000, giving a free cash flow of $78.64 million.
| Operating Cash Flow | 78.86M |
| Capital Expenditures | -225,000 |
| Free Cash Flow | 78.64M |
| FCF Per Share | $0.62 |
Margins
Gross margin is 59.53%, with operating and profit margins of 7.91% and 4.43%.
| Gross Margin | 59.53% |
| Operating Margin | 7.91% |
| Pretax Margin | 4.59% |
| Profit Margin | 4.43% |
| EBITDA Margin | 8.08% |
| EBIT Margin | 7.91% |
| FCF Margin | 7.74% |
Dividends & Yields
APLS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.30% |
| Shareholder Yield | -4.30% |
| Earnings Yield | 1.51% |
| FCF Yield | 2.65% |
Analyst Forecast
The average price target for APLS is $32.16, which is 37.03% higher than the current price. The consensus rating is "Buy".
| Price Target | $32.16 |
| Price Target Difference | 37.03% |
| Analyst Consensus | Buy |
| Analyst Count | 20 |
| Revenue Growth Forecast (5Y) | 13.66% |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
APLS has an Altman Z-Score of 0.95 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.95 |
| Piotroski F-Score | 7 |